Evidence map›Paper›PMID 38610687›Full record

ArticleJournal of clinical medicine2024

Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study.

Fernando Gómez-Peralta, Edelmiro Menéndez, Santiago Conde, Pablo Abellán-Galiana, Miguel Brito, Marina Beléndez, Antonio Pérez, SED1 Study Investigators

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Fernando Gómez-PeraltaEndocrinology and Nutrition Unit, Hospital General de Segovia, 40002 Segovia, Spain.ORCID 0000-0003-0106-0091
Edelmiro MenéndezEndocrinology and Nutrition Service, Hospital Universitario Central Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-9548-7821
Santiago CondeCentro de Salud de Barbastro, 22300 Huesca, Spain.
Pablo Abellán-GalianaDepartment of Endocrinology and Nutrition, Hospital General Universitari de Castelló, 12004 Castellón, Spain.ORCID 0000-0003-1221-3946
Miguel BritoEndocrinology and Nutrition Service, Hospital Puerta de Hierro, 28222 Madrid, Spain.
Marina BeléndezDepartamento de Comunicación y Psicología Social, Universidad de Alicante, 03690 Alicante, Spain.ORCID 0000-0002-5567-1069
Antonio PérezServicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.ORCID 0000-0001-5528-1143
SED1 Study Investigators
Centro de Salud Casa del Barco · ESHospital General De Segovia · ESHospital Universitario Central de Asturias · ESHospital Universitario Puerta de Hierro Majadahonda · ESUniversidad Cardenal Herrera CEU · ESUniversitat Autònoma de Barcelona · ESUniversity of Alicante · ES

Funding

Sanofi (Spain) PC-2020-13146
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

continuous glucose monitoringCOVID-19diabetes complicationsglycemic controltype 1 diabetesvaccination

Identifiers

PMID38610687
PMCPMC11012715
OpenAlexW4393201626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.